Gene May Open Door For New Sickle Cell Therapies, Harvard Medical School Study

CHICAGO (Reuters) - U.S. researchers have discovered a gene switch that could lead to better treatments for sickle cell disease and thalassemia, two inherited blood disorders that affect millions of people, they said on Thursday.

MORE ON THIS TOPIC